Ignite Creation Date:
2025-12-25 @ 12:09 AM
Ignite Modification Date:
2026-03-18 @ 5:03 PM
Study NCT ID:
NCT00674258
Status:
UNKNOWN
Last Update Posted:
2008-05-14
First Post:
2008-05-05
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Histocompatibility Leukocyte Antigen (HLA)-A*2402 Restricted Peptide Vaccine Therapy in Patients With Non-Small Cell Lung Cancer
Sponsor:
Tokyo University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
IMS-NSCLC24
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Department of Infectious Disease and Applied Immunology
Old Organization:
The Institute of Medical Science, The University of Tokyo
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | OTHER | View |